ANGELA BURLESON: Open Payments
NPI 1023587714 · BATESVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 10 payments from 5 companies in 2025. Trend: 2023 $174 · 2024 $208 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 5 | $64 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Evofem Biosciences, Inc. | 1 | $22 |
| Organon LLC | 1 | $18 |
| Exeltis, USA Inc. | 1 | $15 |
Products named: MYFEMBREE, Phexxi, NEXPLANON, SLYND.
Industry payments across AR — which companies pay providers there.
